Oger E - Search Results

1

Safety of Fixed Dose of Antihypertensive Drug Combinations Compared to (Single Pill) Free-Combinations: A Nested Matched Case-Control Analysis.

Nowak E, Happe A, Bouget J, Paillard F, Vigneau C, Scarabin PY, Oger E. Nowak E, et al. Among authors: oger e. Medicine (Baltimore). 2015 Dec;94(49):e2229. doi: 10.1097/MD.0000000000002229. Medicine (Baltimore). 2015. PMID: 26656365 Free PMC article.

2

Re: "Hormone replacement therapy and risk of hospitalization for venous thromboembolism: a population-based study in southern Europe".

Oger E, Scarabin PY. Oger E, et al. Am J Epidemiol. 1999 Feb 1;149(3):292-3. doi: 10.1093/oxfordjournals.aje.a009808. Am J Epidemiol. 1999. PMID: 9927228 No abstract available.

3

Assessment of the risk for venous thromboembolism among users of hormone replacement therapy.

Oger E, Scarabin PY. Oger E, et al. Drugs Aging. 1999 Jan;14(1):55-61. doi: 10.2165/00002512-199914010-00004. Drugs Aging. 1999. PMID: 10069408 Review.

4

Hormone replacement therapy and circulating ICAM-1 in postmenopausal women--a randomised controlled trial.

Scarabin PY, Alhenc-Gelas M, Oger E, Plu-Bureau G. Scarabin PY, et al. Among authors: oger e. Thromb Haemost. 1999 May;81(5):673-5. Thromb Haemost. 1999. PMID: 10365734 Clinical Trial.

5

[Hormone replacement therapy in menopause and the risk of cerebrovascular accident].

Oger E, Scarabin PY. Oger E, et al. Ann Endocrinol (Paris). 1999 Sep;60(3):232-41. Ann Endocrinol (Paris). 1999. PMID: 10520415 French.

6

Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.

Oger E, Alhenc-Gelas M, Plu-Bureau G, Mennen L, Cambillau M, Guize L, Pujol Y, Scarabin P. Oger E, et al. Thromb Res. 2001 Jan 15;101(2):35-43. doi: 10.1016/s0049-3848(00)00382-0. Thromb Res. 2001. PMID: 11342204

7

Diagnostic accuracy of compression ultrasonography for the detection of asymptomatic deep venous thrombosis in medical patients--the TADEUS project.

Bressollette L, Nonent M, Oger E, Garcia JF, Larroche P, Guias B, Scarabin PY, Mottier D. Bressollette L, et al. Among authors: oger e. Thromb Haemost. 2001 Aug;86(2):529-33. Thromb Haemost. 2001. PMID: 11521998

8

The effects of transdermal and oral estrogen/progesterone regimens on free and total protein S in postmenopausal women.

Marque V, Alhenc-Gelas M, Plu-Bureau G, Oger E, Scarabin PY. Marque V, et al. Among authors: oger e. Thromb Haemost. 2001 Aug;86(2):713-4. Thromb Haemost. 2001. PMID: 11522028 No abstract available.

9

Is APC resistance a risk factor for venous thromboembolism in patients over 70 years?

Oger E, Lacut K, Le Gal G, Van Dreden P, Bressollette L, Scarabin PY, Leroyer C, Mottier D. Oger E, et al. Thromb Haemost. 2002 Oct;88(4):587-91. Thromb Haemost. 2002. PMID: 12362228

10

[Deep venous thrombosis: epidemiology, acquired risk factors].

Oger E, Lacut K, Scarabin PY. Oger E, et al. Ann Cardiol Angeiol (Paris). 2002 Jun;51(3):124-8. doi: 10.1016/s0003-3928(02)00083-5. Ann Cardiol Angeiol (Paris). 2002. PMID: 12471641 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters